DARATUMUMAB-BASED COMBINATION THERAPIES IN HEAVILY-PRE-TREATED PATIENTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA

被引：0
|
作者：
Lakshman, A. [1 ]
Abeykoon, J. [2 ]
Kumar, S. [1 ]
Rajkumar, V. [1 ]
Kourelis, T. [1 ]
Buadi, F. [1 ]
Dingli, D. [1 ]
Martha, L. [1 ]
Gonsalves, W. [1 ]
Dispenzieri, A. [1 ]
Kyle, R. [1 ]
Lin, Y. [1 ]
Go, R. [1 ]
Warsame, R. [1 ]
Hobbs, M. [1 ]
Fonder, A. [1 ]
Hwa, Y. [1 ]
Hayman, S. [1 ]
Russell, S. [1 ]
Leung, N. [1 ]
Gertz, M. [1 ]
Kapoor, P. [1 ]
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN USA
[2] Mayo Clin, Internal Med, Rochester, MN USA
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1240
引用
收藏
页码：508 / 508
页数：1
相关论文
共 50 条
  • [41] Management of Patients with Relapsed and/or Refractory Multiple Myeloma Treated with Novel Combination Therapies in Routine Clinical Practice in Germany
    H. Tilman Steinmetz
    Moushmi Singh
    Joseph Milce
    Mohamad Haidar
    Achim Rieth
    Andrea Lebioda
    Jörn Kohnke
    Advances in Therapy, 2022, 39 : 1247 - 1266
  • [42] Immune Profiling of Relapsed/Refractory Multiple Myeloma Patients Treated with Venetoclax in Combination with Dexamethasone (VenDex), Daratumumab and Dexamethasone (VenDd), and Daratumumab, Bortezomib and Dexamethasone (VenDVd)
    Vishwamitra, Deeksha
    Mantis, Christine
    Haribhai, Dipica
    Uziel, Tamar
    Leverson, Joel D.
    Pauff, James M.
    Bueno, Orlando F.
    Maciag, Paulo C.
    Ross, Jeremy A.
    BLOOD, 2019, 134
  • [43] Daratumumab-Based Maintenance in Patients with Relapsed Multiple Myeloma after Salvage Autologous Hematopoietic Stem Cell Transplantation
    Pasvolsky, Oren
    Patel, Krina K.
    Bashir, Qaiser
    Rauf, Mikael
    Sui, Dawen
    Srour, Samer A.
    Tanner, Mark R.
    Popat, Uday R.
    Saini, Neeraj Y.
    Hosing, Chitra
    Ramdial, Jeremy
    Manasanch, Elisabet E.
    Lee, Hans C.
    Kaufman, Gregory P.
    Thomas, Sheeba K.
    Weber, Donna M.
    Becnel, Melody R.
    Tang, Guilin
    Orlowski, Robert Z.
    Patel, Dipa
    Champlin, Richard E.
    Nieto, Yago
    Shpall, Elizabeth J.
    Qazilbash, Muzaffar H.
    BLOOD, 2023, 142
  • [44] Daratumumab-Based Maintenance in Patients with Relapsed Multiple Myeloma after Salvage Autologous Hematopoietic Stem Cell Transplantation
    Aljawai, Yosra
    Pasvolsky, Oren
    Patel, Krina
    Bashir, Qaiser
    Sui, Dawen
    Srour, Samer
    Tanner, Mark
    Popat, Uday
    Saini, Neeraj
    Hosing, Chitra
    Ramdial, Jeremy
    Lee, Hans
    Kaufman, Gregory
    Thomas, Sheeba
    Weber, Donna
    Becnel, Melody
    Tang, Guilin
    Orlowski, Robert
    Patel, Dipa
    Champlin, Richard
    Nieto, Yago
    Shpall, Elizabeth
    Qazilbash, Muzaffar
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S219 - S220
  • [45] EFFECTIVENESS AND SAFETY ANALYSIS OF DARATUMUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Kumar, Seri A.
    Fe, Bitaube R.
    Hinojosa, Orantos C.
    Gavira, Moreno R.
    Garzon, Lopez S.
    HAEMATOLOGICA, 2021, 106 (10) : 339 - 340
  • [46] Listeria Susceptibility in Patients With Multiple Myeloma Receiving Daratumumab-Based Therapy
    Khan, Sahar
    Vaisman, Alon
    Hota, Susy S.
    Bennett, Sabrina
    Trudel, Suzanne
    Reece, Donna
    Tiedemann, Rodger E.
    JAMA ONCOLOGY, 2020, 6 (02) : 293 - 294
  • [47] Subcutaneous delivery of daratumumab in Japanese patients with relapsed/refractory multiple myeloma
    Shibayama, Hirohiko
    Matsumoto, Morio
    Kosugi, Hiroshi
    Shibayama, Kazuhiro
    Yamazaki, Hiroshi
    Iida, Shinsuke
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (01) : 112 - 121
  • [48] Daratumumab plus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma
    Chari, Ajai
    Martinez-Lopez, Joaquin
    Mateos, Maria-Victoria
    Blade, Joan
    Benboubker, Lotfi
    Oriol, Albert
    Arnulf, Bertrand
    Rodriguez-Otero, Paula
    Pineiro, Luis
    Jakubowiak, Andrzej
    de Boer, Carla
    Wang, Jianping
    Clemens, Pamela L.
    Ukropec, Jon
    Schecter, Jordan
    Lonial, Sagar
    Moreau, Philippe
    BLOOD, 2019, 134 (05) : 421 - 431
  • [49] Selinexor, daratumumab, and dexamethasone in patients with relapsed/refractory multiple myeloma (MM).
    Gasparetto, Cristina
    Lentzsch, Suzanne
    Schiller, Gary J.
    Callander, Natalie Scott
    Tuchman, Sascha
    Bahlis, Nizar J.
    White, Darrell
    Chen, Christine
    Baljevic, Muhamed
    Sutherland, Heather J.
    Kotb, Rami
    Sebag, Michael
    LeBlanc, Richard
    Venner, Christopher P.
    Bensinger, William
    Rossi, Adriana C.
    Sheehan, Heidi
    Arazy, Melina
    Kai, Kazuharu
    Lipe, Brea
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [50] Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma
    Papanikolaou, Xenofon
    Szymonifka, Jackie
    Rosenthal, Adam
    Heuck, Christoph J.
    Mitchell, Alan
    Johann, Donald, Jr.
    Keller, Jason
    Waheed, Sarah
    Usmani, Saad Z.
    Van Rhee, Frits
    Bailey, Clyde
    Petty, Nathan
    Hoering, Antje
    Crowley, John
    Barlogie, Bart
    HAEMATOLOGICA, 2013, 98 (07) : 1147 - 1153
12345